The Pharmaceutical Research and Manufacturers of America (PhRMA) launched From Hope to Cures in January 2014 to highlight the value biopharmaceutical innovation provides to patients, society and the economy. As part of the campaign, real stories from people such as Rhys, a 5-year-old with diabetes and celiac disease, Jamie who is fighting a rare blood cancer and Jen, a researcher, who wakes up every day working to find new treatments and cures for patients are featured. The campaign also highlights data and information on fighting diseases, clinical trials and the economic contributions of the biopharmaceutical industry.
Conversations about health care costs are important, but patients need to be at the center. Highlighting the innovation and promise of medicines in development is critical to fostering the development of tomorrow’s cures. Explore Patients, Science, Health Care, and Economy to better understand the ecosystem of innovation in the biopharmaceutical industry.
PhRMA members are leading the way in the search for new treatments and cures, with each step bringing us closer. Learn more at PhRMA.org
We're Fighting Back
For Cancer Survivors Like Matt, Today is a New Opportunity
From Hope to Cures Advertising Campaign
As part of the From Hope to Cures campaign, a collection of advertisements highlighting the stories of patients, families and biopharmaceutical researchers are featured in print, radio, digital and social channels. Advertisements and promotion run on a variety of platforms in Washington, D.C. and select states.